Valuation (93%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 8.07 | N/A |
| PEG Ratio (TTM) | 1.32 | N/A |
| P/S Ratio (TTM) | 0.57 | N/A |
| P/B Ratio (TTM) | 0.83 | N/A |
| P/FCF Ratio (TTM) | 8.21 | N/A |
| Price to 5YR AVG Earnings Ratio | 30.51 | N/A |
| Price to 5YR AVG FCF Ratio | 15.37 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 5.57% | N/A |
| ROE (TTM) | 10.45% | N/A |
| Net Profit Margin (TTM) | 7.15% | N/A |
| ROIC 5YR AVG | 6.29% | N/A |
Growth (42%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 29.81% | -1,127.24% | -659.82% |
| Revenue | 2.33% | 2.42% | 7.27% |
| Net Income | 30.34% | -1,125.77% | -656.92% |
| Cash Flow | 26.74% | -4.90% | 9.98% |
Health (63%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.71 | N/A |
| Quick Ratio (TTM) | 1.99 | N/A |
| D/E Ratio (TTM) | 0.41 | N/A |
| Interest Coverage (TTM) | 8.27 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 2.49 | N/A |
| LTL to 5YR AVG FCF | 9.32 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.14% | N/A |